Transgenic and knock-in mice with the H530R PRKAG2 mutation replicated human symptoms of ventricular hypertrophy and glycogen storage, suggesting a causal link to PRKAG2 cardiac syndrome. Here, PRKAG2 is linked to cardiac hypertrophy.